Biotechnology
The Biotechnology industry has a total of 586 stocks, with a combined market cap of $1.31 trillion and total revenue of $116.09 billion.
Market Cap
1.31T
Revenue
116.09B
Profits
-38.86B
PE Ratio
n/a
Profit Margin
-33.47%
Dividend Yield
0.04%
586 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 130.87B | -0.92% | 344,617 | 12.59B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 79.49B | -1.44% | 264,481 | 15.53B |
| 3 | ARGX | argenx SE | 62.23B | -1.59% | 181,408 | 5.32B |
| 4 | MRNA | Moderna, Inc. | 54.42B | 0.52% | 6,232,420 | 2.23B |
| 5 | RVMD | Revolution Medicines, Inc. | 43.52B | -2.23% | 487,260 | - |
| 6 | ONC | BeOne Medicines AG | 39.16B | -1.89% | 585,649 | 6.13B |
| 7 | RPRX | Royalty Pharma plc | 33.98B | -2.46% | 1,869,906 | 2.54B |
| 8 | ALNY | Alnylam Pharmaceuticals, Inc. | 33.22B | -3.78% | 1,010,138 | 4.80B |
| 9 | ROIV | Roivant Sciences Ltd. | 29.36B | -2.80% | 4,234,935 | 7.53M |
| 10 | INSM | Insmed Incorporated | 27.79B | -1.19% | 1,173,586 | 1.14B |
| 11 | INCY | Incyte Corporation | 25.03B | -2.01% | 1,018,421 | 5.82B |
| 12 | BNTX | BioNTech SE | 24.15B | -2.04% | 407,937 | 3.03B |
| 13 | GMAB | Genmab A/S | 19.36B | -2.19% | 752,799 | 4.13B |
| 14 | ASND | Ascendis Pharma A/S | 17.08B | -0.26% | 289,895 | 1.20B |
| 15 | JAZZ | Jazz Pharmaceuticals plc | 15.68B | 0.07% | 545,882 | 4.60B |
| 16 | EXEL | Exelixis, Inc. | 14.26B | -1.30% | 722,190 | 2.44B |
| 17 | BBIO | BridgeBio Pharma, Inc. | 14.23B | -4.32% | 1,543,298 | 713.07M |
| 18 | SMMT | Summit Therapeutics Inc. | 13.51B | -3.45% | 2,923,775 | - |
| 19 | BMRN | BioMarin Pharmaceutical Inc. | 12.65B | 1.46% | 1,071,800 | 3.41B |
| 20 | CORT | Corcept Therapeutics Incorporated | 12.35B | -1.28% | 313,691 | 830.81M |
| 21 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.25B | -3.02% | 161,532 | 1.28B |
| 22 | HALO | Halozyme Therapeutics, Inc. | 12.16B | -0.22% | 623,457 | 1.66B |
| 23 | ARWR | Arrowhead Pharmaceuticals, Inc. | 11.71B | 0.32% | 518,776 | 669.50M |
| 24 | TECH | Bio-Techne Corporation | 11.32B | -0.06% | 2,025,721 | 1.22B |
| 25 | AXSM | Axsome Therapeutics, Inc. | 10.99B | -0.43% | 246,809 | 776.57M |
| 26 | CYTK | Cytokinetics, Incorporated | 10.28B | -0.19% | 824,824 | 67.67M |
| 27 | KRYS | Krystal Biotech, Inc. | 10.25B | -0.56% | 98,404 | 440.48M |
| 28 | ABVX | ABIVAX Société Anonyme | 10.17B | -4.16% | 980,583 | 5.67M |
| 29 | KYMR | Kymera Therapeutics, Inc. | 9.77B | 1.75% | 384,862 | 105.00M |
| 30 | PRAX | Praxis Precision Medicines, Inc. | 9.48B | -1.62% | 150,663 | 7.46M |
| 31 | PTGX | Protagonist Therapeutics, Inc. | 9.32B | -0.68% | 283,572 | 281.99M |
| 32 | IONS | Ionis Pharmaceuticals, Inc. | 9.19B | -1.25% | 1,716,543 | 874.09M |
| 33 | PCVX | Vaxcyte, Inc. | 8.80B | -0.58% | 746,343 | - |
| 34 | IBRX | ImmunityBio, Inc. | 8.18B | -4.22% | 6,301,990 | 165.79M |
| 35 | TWST | Twist Bioscience Corporation | 7.95B | 1.05% | 791,937 | 431.80M |
| 36 | IMVT | Immunovant, Inc. | 7.83B | -2.19% | 651,910 | - |
| 37 | TGTX | TG Therapeutics, Inc. | 7.80B | 0.59% | 655,262 | 799.54M |
| 38 | SYRE | Spyre Therapeutics, Inc. | 7.75B | 1.15% | 545,198 | - |
| 39 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.05B | 1.38% | 247,666 | 239.92M |
| 40 | BLTE | Belite Bio, Inc | 6.99B | -5.19% | 137,863 | - |
| 41 | SRRK | Scholar Rock Holding Corporation | 6.74B | 1.34% | 685,317 | - |
| 42 | CAI | Caris Life Sciences, Inc. | 6.73B | -0.83% | 1,785,718 | 989.61M |
| 43 | MIRM | Mirum Pharmaceuticals, Inc. | 6.53B | 2.33% | 362,968 | 618.07M |
| 44 | CGON | CG Oncology, Inc. | 6.35B | -0.42% | 263,871 | 6.23M |
| 45 | TVTX | Travere Therapeutics, Inc. | 6.33B | 1.36% | 998,475 | 591.33M |
| 46 | ORKA | Oruka Therapeutics, Inc. | 6.05B | -0.12% | 347,274 | - |
| 47 | COGT | Cogent Biosciences, Inc. | 5.90B | -0.63% | 1,389,284 | - |
| 48 | DNTH | Dianthus Therapeutics, Inc. | 5.87B | -1.88% | 300,064 | 1.90M |
| 49 | LGND | Ligand Pharmaceuticals Incorporated | 5.77B | 0.40% | 68,974 | 290.54M |
| 50 | XENE | Xenon Pharmaceuticals Inc. | 5.66B | -0.83% | 531,054 | 7.50M |
| 51 | PTCT | PTC Therapeutics, Inc. | 5.62B | -0.30% | 443,549 | 1.01B |
| 52 | ERAS | Erasca, Inc. | 5.61B | 2.10% | 6,618,549 | - |
| 53 | DFTX | Definium Therapeutics, Inc. | 5.07B | -0.74% | 870,252 | - |
| 54 | CRSP | CRISPR Therapeutics AG | 5.05B | -2.34% | 875,761 | 13.39M |
| 55 | ACAD | ACADIA Pharmaceuticals Inc. | 4.77B | 0.07% | 540,528 | 1.14B |
| 56 | EWTX | Edgewise Therapeutics, Inc. | 4.69B | -0.46% | 425,373 | - |
| 57 | PBLS | Parabilis Medicines, Inc. | 4.51B | -5.77% | 497,736 | 148.00K |
| 58 | CELC | Celcuity Inc. | 4.20B | -4.75% | 757,383 | - |
| 59 | RLAY | Relay Therapeutics, Inc. | 4.19B | 2.36% | 1,980,376 | 10.35M |
| 60 | MANE | Veradermics, Incorporated | 4.14B | -0.64% | 251,675 | - |
| 61 | ELVN | Enliven Therapeutics, Inc. | 4.12B | -2.02% | 466,751 | - |
| 62 | TLX | Telix Pharmaceuticals Limited | 4.08B | -3.32% | 279,026 | 890.79M |
| 63 | TNGX | Tango Therapeutics, Inc. | 3.96B | -2.17% | 2,446,485 | 53.81M |
| 64 | VKTX | Viking Therapeutics, Inc. | 3.77B | -1.16% | 1,300,410 | - |
| 65 | LEGN | Legend Biotech Corporation | 3.75B | -2.91% | 1,409,575 | 1.27B |
| 66 | IOVA | Iovance Biotherapeutics, Inc. | 3.67B | -3.86% | 8,232,964 | 324.97M |
| 67 | IDYA | IDEAYA Biosciences, Inc. | 3.63B | -1.80% | 327,773 | 234.13M |
| 68 | TARS | Tarsus Pharmaceuticals, Inc. | 3.56B | -1.93% | 249,448 | 606.33M |
| 69 | DNLI | Denali Therapeutics Inc. | 3.41B | -0.97% | 549,978 | 3.60M |
| 70 | DYN | Dyne Therapeutics, Inc. | 3.41B | -4.85% | 3,153,102 | - |
| 71 | ABCL | AbCellera Biologics Inc. | 3.40B | -5.07% | 3,985,201 | 66.17M |
| 72 | RCUS | Arcus Biosciences, Inc. | 3.38B | -6.81% | 1,529,010 | 117.00M |
| 73 | QURE | uniQure N.V. | 3.13B | -1.96% | 601,401 | 18.67M |
| 74 | CLDX | Celldex Therapeutics, Inc. | 3.02B | -0.75% | 380,673 | 158.00K |
| 75 | MBX | MBX Biosciences, Inc. | 2.95B | -2.64% | 284,341 | - |
| 76 | ARQT | Arcutis Biotherapeutics, Inc. | 2.94B | -1.76% | 1,185,516 | 463.98M |
| 77 | IMNM | Immunome, Inc. | 2.87B | -3.29% | 370,393 | 4.02M |
| 78 | IRON | Disc Medicine, Inc. | 2.85B | -3.07% | 323,422 | - |
| 79 | GPCR | Structure Therapeutics Inc. | 2.82B | -4.11% | 436,103 | - |
| 80 | SLS | SELLAS Life Sciences Group, Inc. | 2.74B | -2.80% | 3,975,857 | - |
| 81 | ATAI | AtaiBeckley Inc. | 2.72B | 0.62% | 6,363,203 | 4.47M |
| 82 | ZLAB | Zai Lab Limited | 2.71B | -3.75% | 933,451 | 449.61M |
| 83 | NRIX | Nurix Therapeutics, Inc. | 2.68B | -1.81% | 592,404 | 36.77M |
| 84 | NAMS | NewAmsterdam Pharma Company N.V. | 2.64B | -3.20% | 2,188,627 | 7.12M |
| 85 | PHVS | Pharvaris N.V. | 2.64B | -0.50% | 963,130 | - |
| 86 | MLYS | Mineralys Therapeutics, Inc. | 2.61B | -3.20% | 448,094 | - |
| 87 | VRDN | Viridian Therapeutics, Inc. | 2.50B | -2.77% | 785,552 | 71.13M |
| 88 | BEAM | Beam Therapeutics Inc. | 2.44B | -3.16% | 1,390,309 | 156.04M |
| 89 | NKTR | Nektar Therapeutics | 2.43B | -2.97% | 342,432 | 54.59M |
| 90 | VERA | Vera Therapeutics, Inc. | 2.40B | -1.21% | 1,304,579 | - |
| 91 | HRMY | Harmony Biosciences Holdings, Inc. | 2.39B | -1.37% | 370,539 | 959.90M |
| 92 | PGEN | Precigen, Inc. | 2.38B | -2.13% | 1,956,978 | 85.72M |
| 93 | OCUL | Ocular Therapeutix, Inc. | 2.34B | -7.24% | 1,676,520 | 52.06M |
| 94 | TRVI | Trevi Therapeutics, Inc. | 2.26B | -4.69% | 718,498 | - |
| 95 | NUVB | Nuvation Bio Inc. | 2.22B | -2.84% | 7,510,786 | 169.90M |
| 96 | SRPT | Sarepta Therapeutics, Inc. | 2.17B | -6.77% | 1,452,087 | 1.97B |
| 97 | PVLA | Palvella Therapeutics, Inc. | 2.16B | -0.89% | 201,355 | - |
| 98 | AUPH | Aurinia Pharmaceuticals Inc. | 2.13B | -1.29% | 458,501 | 311.51M |
| 99 | ADMA | ADMA Biologics, Inc. | 2.11B | -0.42% | 1,510,971 | 512.28M |
| 100 | KOD | Kodiak Sciences Inc. | 2.08B | -1.89% | 403,274 | - |
| 101 | RAPP | Rapport Therapeutics, Inc. | 2.08B | -1.45% | 195,813 | 20.00M |
| 102 | URGN | UroGen Pharma Ltd. | 2.07B | -6.10% | 434,583 | 188.73M |
| 103 | ZBIO | Zenas BioPharma, Inc. | 2.03B | -3.78% | 387,412 | 1.00M |
| 104 | MESO | Mesoblast Limited | 2.02B | -4.21% | 151,077 | 120.25M |
| 105 | AGIO | Agios Pharmaceuticals, Inc. | 2.00B | -3.12% | 401,025 | 98.34M |
| 106 | GENB | Generate Biomedicines, Inc. | 2.00B | 0.45% | 763,577 | 26.48M |
| 107 | BHVN | Biohaven Ltd. | 1.97B | -12.97% | 6,137,727 | - |
| 108 | VCEL | Vericel Corporation | 1.93B | -3.18% | 229,905 | 306.30M |
| 109 | KLRA | Kailera Therapeutics, Inc. | 1.93B | 0.27% | 434,605 | - |
| 110 | STOK | Stoke Therapeutics, Inc. | 1.89B | -2.01% | 256,949 | 27.59M |
| 111 | ZYME | Zymeworks Inc. | 1.88B | -2.21% | 238,500 | 37.13M |
| 112 | COAG | Hemab Therapeutics Holdings, Inc. | 1.86B | -10.63% | 298,070 | - |
| 113 | GHRS | GH Research PLC | 1.85B | -2.25% | 77,397 | - |
| 114 | NBTX | Nanobiotix S.A. | 1.84B | 4.18% | 176,860 | 38.27M |
| 115 | VIR | Vir Biotechnology, Inc. | 1.81B | -1.02% | 1,058,859 | 303.23M |
| 116 | XNCR | Xencor, Inc. | 1.81B | -2.53% | 991,908 | 104.97M |
| 117 | LKFT | Lakefront Biotherapeutics NV | 1.80B | -1.95% | 133,978 | 1.13B |
| 118 | KARD | Kardigan, Inc. | 1.77B | -4.07% | 320,098 | - |
| 119 | SEPN | Septerna, Inc. | 1.76B | -0.53% | 214,908 | 98.88M |
| 120 | BRVE | Braveheart Bio, Inc. | 1.74B | -6.30% | 211,397 | - |
| 121 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.73B | -3.96% | 1,445,909 | 208.78M |
| 122 | IMCR | Immunocore Holdings plc | 1.72B | -2.93% | 157,809 | 430.78M |
| 123 | RXRX | Recursion Pharmaceuticals, Inc. | 1.70B | -1.56% | 8,510,986 | 54.86M |
| 124 | TSHA | Taysha Gene Therapies, Inc. | 1.67B | -3.75% | 1,448,663 | 5.49M |
| 125 | SNDX | Syndax Pharmaceuticals, Inc. | 1.67B | -5.65% | 1,096,913 | 252.25M |
| 126 | NTLA | Intellia Therapeutics, Inc. | 1.67B | -2.58% | 2,951,759 | 59.51M |
| 127 | DMRA | Damora Therapeutics, Inc. | 1.66B | 2.13% | 289,413 | - |
| 128 | ANAB | AnaptysBio, Inc. | 1.63B | -1.38% | 166,733 | 232.39M |
| 129 | INBX | Inhibrx Biosciences, Inc. | 1.62B | -2.39% | 234,557 | 1.30M |
| 130 | FTRE | Fortrea Holdings Inc. | 1.60B | 0.24% | 466,689 | 2.68B |
| 131 | NVAX | Novavax, Inc. | 1.54B | -4.92% | 4,386,358 | 413.80M |
| 132 | BCAX | Bicara Therapeutics Inc. | 1.54B | -1.65% | 396,497 | - |
| 133 | AVLN | Avalyn Pharma Inc. | 1.54B | -3.32% | 70,660 | - |
| 134 | AAPG | Ascentage Pharma Group International | 1.53B | -3.58% | 2,829 | 94.61M |
| 135 | LBRX | LB Pharmaceuticals Inc | 1.50B | -2.46% | 120,178 | - |
| 136 | INVA | Innoviva, Inc. | 1.50B | -1.85% | 315,975 | 440.00M |
| 137 | APMD | Apnimed, Inc. | 1.48B | -5.06% | 162,375 | 120.15M |
| 138 | LTGO | Latigo Biotherapeutics, Inc. | 1.45B | -4.39% | 118,389 | - |
| 139 | AVBP | ArriVent BioPharma, Inc. | 1.42B | -3.19% | 432,697 | - |
| 140 | ABSI | Absci Corporation | 1.42B | -4.51% | 2,083,746 | 1.56M |
| 141 | RARE | Ultragenyx Pharmaceutical Inc. | 1.41B | 0.07% | 2,137,782 | 717.00M |
| 142 | TYRA | Tyra Biosciences, Inc. | 1.40B | 6.68% | 2,006,252 | - |
| 143 | TRAX | First Tracks Biotherapeutics, Inc. | 1.37B | -3.41% | 214,318 | - |
| 144 | MAZE | Maze Therapeutics, Inc. | 1.36B | -0.24% | 965,753 | 20.00M |
| 145 | CGEM | Cullinan Therapeutics, Inc. | 1.35B | -1.22% | 571,631 | - |
| 146 | SVRA | Savara Inc. | 1.35B | -1.75% | 1,178,575 | - |
| 147 | OMER | Omeros Corporation | 1.34B | -4.18% | 885,953 | 38.42M |
| 148 | DRTS | Alpha Tau Medical Ltd. | 1.34B | 1.61% | 365,402 | - |
| 149 | AKTS | Aktis Oncology, Inc. | 1.33B | -0.25% | 168,015 | 10.06M |
| 150 | VOR | Vor Biopharma Inc. | 1.32B | -3.98% | 433,394 | - |
| 151 | ALMS | Alumis Inc. | 1.28B | 1.22% | 3,327,799 | 7.40M |
| 152 | ORIC | ORIC Pharmaceuticals, Inc. | 1.26B | -2.72% | 566,381 | - |
| 153 | REPL | Replimune Group, Inc. | 1.26B | -7.47% | 2,155,277 | - |
| 154 | ANRO | Alto Neuroscience, Inc. | 1.25B | -6.69% | 623,099 | - |
| 155 | SPTX | Seaport Therapeutics, Inc. | 1.23B | 6.07% | 106,697 | - |
| 156 | MGTX | MeiraGTx Holdings plc | 1.23B | -3.09% | 464,829 | 397.50M |
| 157 | JBIO | Jade Biosciences, Inc. | 1.21B | 0.16% | 923,371 | - |
| 158 | MNKD | MannKind Corporation | 1.21B | -4.31% | 2,333,675 | 393.63M |
| 159 | GLUE | Monte Rosa Therapeutics, Inc. | 1.21B | -0.63% | 627,253 | 28.73M |
| 160 | IMTX | Immatics N.V. | 1.20B | -3.62% | 581,648 | 47.65M |
| 161 | SLBT | SL Science Holding Limited | 1.17B | -21.65% | 265,012 | 3.27M |
| 162 | ODTX | Odyssey Therapeutics, Inc. | 1.15B | -2.33% | 147,584 | 99.00K |
| 163 | MLTX | MoonLake Immunotherapeutics | 1.13B | -3.50% | 889,977 | - |
| 164 | CRVS | Corvus Pharmaceuticals, Inc. | 1.10B | -1.80% | 704,691 | - |
| 165 | JANX | Janux Therapeutics, Inc. | 1.09B | -8.12% | 558,444 | 24.00M |
| 166 | OBX | Obsidian Therapeutics, Inc. | 1.08B | -6.64% | 401,593 | - |
| 167 | KURA | Kura Oncology, Inc. | 1.03B | -4.30% | 1,280,543 | 77.23M |
| 168 | ATTO | Attovia Therapeutics, Inc. | 1.02B | -1.92% | 126,753 | 1.80M |
| 169 | FTH | Faeth Therapeutics, Inc. | 1.01B | 8.72% | 327,042 | - |
| 170 | ABUS | Arbutus Biopharma Corporation | 1.01B | -1.16% | 1,612,116 | 181.72M |
| 171 | IVA | Inventiva S.A. | 1.01B | -5.84% | 615,027 | 7.94M |
| 172 | ANL | Adlai Nortye Group Ltd. | 1.00B | 6.09% | 158,747 | 18.06M |
| 173 | SLDB | Solid Biosciences Inc. | 976.82M | -4.51% | 510,085 | - |
| 174 | HELP | Cybin Inc. | 940.28M | -5.92% | 1,470,687 | - |
| 175 | AVTX | Avalo Therapeutics, Inc. | 936.38M | -4.12% | 627,541 | 59.00K |
| 176 | OLMA | Olema Pharmaceuticals, Inc. | 928.35M | 2.41% | 703,595 | - |
| 177 | WVE | Wave Life Sciences, Inc. | 927.11M | -2.18% | 1,837,157 | 65.37M |
| 178 | DSGN | Design Therapeutics, Inc. | 925.58M | -1.53% | 425,326 | - |
| 179 | SANA | Sana Biotechnology, Inc. | 917.54M | -3.31% | 3,738,555 | - |
| 180 | SGP | SpyGlass Pharma, Inc. | 916.14M | -0.40% | 61,392 | - |
| 181 | ARDX | Ardelyx, Inc. | 907.04M | -4.21% | 2,790,221 | 450.89M |
| 182 | IMMX | Immix Biopharma, Inc. | 903.54M | 2.60% | 1,007,373 | - |
| 183 | LXRX | Lexicon Pharmaceuticals, Inc. | 903.26M | -5.58% | 1,813,886 | 41.47M |
| 184 | TBPH | Theravance Biopharma, Inc. | 884.44M | -0.15% | 188,824 | 104.31M |
| 185 | GERN | Geron Corporation | 883.40M | -1.79% | 5,467,041 | 204.56M |
| 186 | RIGL | Rigel Pharmaceuticals, Inc. | 875.34M | -0.76% | 50,542 | 276.79M |
| 187 | CADL | Candel Therapeutics, Inc. | 867.72M | -6.82% | 1,451,364 | - |
| 188 | CLYM | Climb Bio, Inc. | 852.35M | -1.40% | 910,314 | - |
| 189 | CBIO | Crescent Biopharma, Inc. | 844.89M | -1.25% | 155,382 | 11.88M |
| 190 | ACRS | Aclaris Therapeutics, Inc. | 816.95M | -0.18% | 1,670,277 | 8.22M |
| 191 | SLN | Silence Therapeutics plc | 803.79M | -1.48% | 492,045 | 615.00K |
| 192 | ANNX | Annexon, Inc. | 780.12M | -5.84% | 2,633,851 | - |
| 193 | DBVT | DBV Technologies S.A. | 779.01M | -3.31% | 100,313 | 5.04M |
| 194 | MPLT | MapLight Therapeutics, Inc. | 770.84M | 1.17% | 332,530 | - |
| 195 | PHAR | Pharming Group N.V. | 760.78M | -2.10% | 14,756 | 366.48M |
| 196 | ACHV | Achieve Life Sciences, Inc. | 749.13M | -3.45% | 2,059,999 | - |
| 197 | FDMT | 4D Molecular Therapeutics, Inc. | 745.80M | -4.80% | 346,627 | 92.01M |
| 198 | MNPR | Monopar Therapeutics Inc. | 741.23M | -1.74% | 70,029 | - |
| 199 | CTMX | CytomX Therapeutics, Inc. | 740.86M | -3.95% | 1,399,966 | 18.30M |
| 200 | NVCT | Nuvectis Pharma, Inc. | 739.60M | -0.35% | 63,838 | - |
| 201 | NGNE | Neurogene Inc. | 727.41M | -4.04% | 124,944 | 925.00K |
| 202 | AURA | Aura Biosciences, Inc. | 722.82M | -3.19% | 535,494 | - |
| 203 | GYRE | Gyre Therapeutics, Inc. | 718.91M | -2.45% | 62,127 | 109.82M |
| 204 | ZVRA | Zevra Therapeutics, Inc. | 716.17M | 0.17% | 367,735 | 136.07M |
| 205 | OCS | Oculis Holding AG | 695.72M | -1.74% | 111,659 | 1.45M |
| 206 | SGMT | Sagimet Biosciences Inc. | 692.45M | 2.58% | 693,131 | - |
| 207 | AGMB | AgomAb Therapeutics NV | 686.52M | -6.82% | 91,272 | - |
| 208 | VSTM | Verastem, Inc. | 685.57M | -4.66% | 1,920,480 | 87.53M |
| 209 | PHAT | Phathom Pharmaceuticals, Inc. | 667.21M | -3.11% | 755,141 | 239.66M |
| 210 | BLSM | BlossomHill Therapeutics, Inc. | 660.98M | -1.95% | 133,457 | - |
| 211 | MDXG | MiMedx Group, Inc. | 658.84M | -3.42% | 1,145,730 | 355.17M |
| 212 | DRUG | Bright Minds Biosciences Inc. | 642.77M | 0.58% | 67,505 | - |
| 213 | VALN | Valneva SE | 638.85M | 0.60% | 33,439 | 163.30M |
| 214 | ALT | Altimmune, Inc. | 638.02M | -2.09% | 1,845,147 | 31.00K |
| 215 | ASMB | Assembly Biosciences, Inc. | 626.70M | -6.36% | 260,333 | 74.85M |
| 216 | STTK | Shattuck Labs, Inc. | 624.26M | -1.74% | 805,368 | 1.00M |
| 217 | CRMD | CorMedix Inc. | 621.22M | -1.97% | 583,736 | 462.25M |
| 218 | ALLO | Allogene Therapeutics, Inc. | 611.52M | 2.31% | 4,271,679 | 4.64M |
| 219 | PRME | Prime Medicine, Inc. | 595.96M | -3.46% | 1,592,501 | 4.07M |
| 220 | OABI | OmniAb, Inc. | 574.29M | -1.62% | 820,778 | 38.46M |
| 221 | ARVN | Arvinas, Inc. | 566.90M | -1.03% | 557,471 | 316.70M |
| 222 | TECX | Tectonic Therapeutic, Inc. | 565.95M | -5.02% | 120,887 | - |
| 223 | RGNX | REGENXBIO Inc. | 565.07M | -1.95% | 691,392 | 174.48M |
| 224 | CTNM | Contineum Therapeutics, Inc. | 560.18M | -1.65% | 123,669 | - |
| 225 | PROK | ProKidney Corp. | 559.30M | - | 2,177,910 | 818.00K |
| 226 | SCTX | Scribe Therapeutics Inc. | 549.02M | -1.39% | 154,961 | 33.30M |
| 227 | EPRX | Eupraxia Pharmaceuticals Inc. | 529.14M | -0.37% | 182,840 | - |
| 228 | AUTL | Autolus Therapeutics plc | 523.01M | -3.20% | 931,659 | 117.39M |
| 229 | ZURA | Zura Bio Limited | 520.35M | -4.90% | 693,224 | - |
| 230 | OVID | Ovid Therapeutics Inc. | 516.56M | -2.04% | 795,861 | 1.58M |
| 231 | IRD | Opus Genetics, Inc. | 512.90M | 7.59% | 5,385,183 | 9.86M |
| 232 | EIKN | Eikon Therapeutics, Inc. | 510.78M | -12.12% | 437,739 | - |
| 233 | ARTV | Artiva Biotherapeutics, Inc. | 509.44M | -3.43% | 328,577 | 251.00K |
| 234 | SPRY | ARS Pharmaceuticals, Inc. | 503.70M | -3.15% | 693,823 | 116.93M |
| 235 | PRLD | Prelude Therapeutics Incorporated | 492.32M | -6.09% | 365,489 | 22.42M |
| 236 | ENTX | Entera Bio Ltd. | 484.80M | -1.41% | 408,791 | 42.00K |
| 237 | CAPR | Capricor Therapeutics, Inc. | 481.39M | -4.17% | 1,890,642 | 11.13M |
| 238 | PBYI | Puma Biotechnology, Inc. | 474.13M | 1.49% | 103,140 | 231.24M |
| 239 | CABA | Cabaletta Bio, Inc. | 472.18M | -4.30% | 5,493,287 | - |
| 240 | PRTA | Prothena Corporation plc | 465.11M | -2.58% | 168,173 | 54.53M |
| 241 | DNA | Ginkgo Bioworks Holdings, Inc. | 458.59M | 0.29% | 386,779 | 132.42M |
| 242 | KYTX | Kyverna Therapeutics, Inc. | 456.40M | -3.40% | 641,721 | - |
| 243 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 449.78M | -16.95% | 2,399,597 | - |
| 244 | RZLT | Rezolute, Inc. | 436.67M | 2.96% | 1,599,829 | - |
| 245 | RLMD | Relmada Therapeutics, Inc. | 433.08M | -0.73% | 2,389,684 | - |
| 246 | IKT | Inhibikase Therapeutics, Inc. | 425.14M | -3.11% | 218,961 | 1.00 |
| 247 | AVIR | Atea Pharmaceuticals, Inc. | 421.48M | -0.28% | 145,122 | - |
| 248 | BNTC | Benitec Biopharma Inc. | 420.84M | -1.61% | 60,822 | - |
| 249 | VOGX | Vogenx, Inc. | 419.20M | 1.07% | 107,747 | - |
| 250 | CCCC | C4 Therapeutics, Inc. | 415.21M | -1.89% | 873,087 | 35.04M |
| 251 | EDIT | Editas Medicine, Inc. | 406.99M | -4.33% | 1,693,655 | 47.01M |
| 252 | TTRX | Turn Therapeutics Inc. | 405.42M | -1.02% | 88,549 | - |
| 253 | ARCT | Arcturus Therapeutics Holdings Inc. | 403.61M | -3.66% | 763,118 | 29.37M |
| 254 | VTVT | vTv Therapeutics Inc. | 399.83M | -3.33% | 41,783 | 36.84M |
| 255 | LRMR | Larimar Therapeutics, Inc. | 399.26M | -1.16% | 633,683 | - |
| 256 | FENC | Fennec Pharmaceuticals Inc. | 397.31M | -2.75% | 105,881 | 59.22M |
| 257 | GALT | Galectin Therapeutics Inc. | 396.34M | -2.96% | 200,145 | - |
| 258 | EVMN | Evommune, Inc. | 390.50M | -0.74% | 512,273 | 10.00M |
| 259 | RCKT | Rocket Pharmaceuticals, Inc. | 380.92M | -4.41% | 807,697 | - |
| 260 | CMPX | Compass Therapeutics, Inc. | 371.88M | -5.28% | 1,818,832 | 850.00K |
| 261 | EYPT | EyePoint, Inc. | 366.83M | -1.96% | 3,454,532 | 2.79M |
| 262 | ENTA | Enanta Pharmaceuticals, Inc. | 365.82M | -5.14% | 167,767 | 65.26M |
| 263 | LXEO | Lexeo Therapeutics, Inc. | 359.35M | -2.23% | 262,040 | - |
| 264 | OBIO | Orchestra BioMed Holdings, Inc. | 358.23M | 9.36% | 656,090 | 31.98M |
| 265 | PALI | Palisade Bio, Inc. | 352.03M | -1.46% | 2,083,285 | 500.00K |
| 266 | IPSC | Century Therapeutics, Inc. | 351.29M | -4.43% | 387,361 | 109.16M |
| 267 | OCGN | Ocugen, Inc. | 345.89M | -4.23% | 20,048,567 | 4.58M |
| 268 | DMAC | DiaMedica Therapeutics Inc. | 344.59M | -3.03% | 125,952 | - |
| 269 | ZNTL | Zentalis Pharmaceuticals, Inc. | 343.66M | -4.47% | 613,783 | 26.87M |
| 270 | XFOR | X4 Pharmaceuticals, Inc. | 340.57M | -4.58% | 2,067,202 | 15.85M |
| 271 | SION | Sionna Therapeutics, Inc. | 340.45M | 0.67% | 653,611 | - |
| 272 | INDP | Indaptus Therapeutics, Inc. | 335.77M | 21.15% | 2,941,860 | - |
| 273 | VCRE | Vicore Pharma Holding AB (publ) | 334.21M | -4.88% | 22,866 | 412.09K |
| 274 | QTTB | Q32 Bio Inc. | 319.43M | -3.68% | 758,100 | 53.74M |
| 275 | UPB | Upstream Bio, Inc. | 316.58M | -3.02% | 369,503 | 3.16M |
| 276 | ABEO | Abeona Therapeutics Inc. | 314.51M | -5.01% | 1,867,350 | 25.52M |
| 277 | AGEN | Agenus Inc. | 311.99M | 1.02% | 583,474 | 132.69M |
| 278 | SABS | SAB Biotherapeutics, Inc. | 311.17M | -1.72% | 216,555 | 114.70K |
| 279 | VNDA | Vanda Pharmaceuticals Inc. | 305.34M | -3.81% | 662,845 | 215.72M |
| 280 | IFRX | InflaRx N.V. | 300.63M | -2.39% | 470,169 | -11.54K |
| 281 | LYEL | Lyell Immunopharma, Inc. | 298.72M | -5.36% | 82,064 | 27.00K |
| 282 | IMRX | Immuneering Corporation | 297.61M | -0.22% | 498,869 | - |
| 283 | STRO | Sutro Biopharma, Inc. | 295.97M | -2.75% | 101,897 | 45.70M |
| 284 | CUVL | Clinuvel Pharmaceuticals Limited | 291.27M | 0.51% | 18,404 | 65.05M |
| 285 | FULC | Fulcrum Therapeutics, Inc. | 290.31M | -0.91% | 958,434 | 80.00M |
| 286 | FATE | Fate Therapeutics, Inc. | 280.38M | -4.10% | 607,015 | 6.49M |
| 287 | PRQR | ProQR Therapeutics N.V. | 271.66M | -3.27% | 393,882 | 21.05M |
| 288 | CAMP | Camp4 Therapeutics Corporation | 270.47M | -0.46% | 66,418 | 4.22M |
| 289 | PYXS | Pyxis Oncology, Inc. | 270.24M | -4.14% | 622,458 | 11.04M |
| 290 | YDES | YD Bio Limited | 269.32M | -2.42% | 629,812 | 510.36K |
| 291 | BCYC | Bicycle Therapeutics plc | 267.37M | -4.62% | 1,470,299 | 61.21M |
| 292 | ACIU | AC Immune SA | 266.96M | -2.72% | 124,506 | 21.67M |
| 293 | FHTX | Foghorn Therapeutics Inc. | 266.94M | -3.75% | 263,358 | 36.74M |
| 294 | ALXO | ALX Oncology Holdings Inc. | 257.89M | 1.36% | 759,841 | - |
| 295 | LCTX | Lineage Cell Therapeutics, Inc. | 256.70M | -1.46% | 929,117 | 13.08M |
| 296 | RNAC | Cartesian Therapeutics, Inc. | 255.05M | -2.99% | 102,363 | 1.48M |
| 297 | MGNX | MacroGenics, Inc. | 253.21M | -3.28% | 300,688 | 175.14M |
| 298 | AVXL | Anavex Life Sciences Corp. | 246.11M | -3.45% | 323,104 | - |
| 299 | ALEC | Alector, Inc. | 239.50M | -5.51% | 3,410,370 | 13.86M |
| 300 | VRXA | Veraxa Biotech AG | 234.74M | 4.40% | 379,094 | 29.54K |
| 301 | TRDA | Entrada Therapeutics, Inc. | 234.73M | -8.44% | 281,200 | 4.69M |
| 302 | CGEN | Compugen Ltd. | 233.02M | -0.81% | 186,537 | 74.00M |
| 303 | IVVD | Invivyd, Inc. | 231.59M | -1.45% | 1,565,174 | 58.37M |
| 304 | CLLS | Cellectis S.A. | 231.49M | 0.73% | 36,224 | 63.82M |
| 305 | SRZN | Surrozen, Inc. | 230.66M | -2.02% | 227,677 | 11.51M |
| 306 | NGEN | NervGen Pharma Corp. | 230.64M | 0.70% | 232,352 | - |
| 307 | WHWK | Whitehawk Therapeutics, Inc. | 229.75M | -3.82% | 1,207,193 | 7.15M |
| 308 | ELDN | Eledon Pharmaceuticals, Inc. | 226.54M | -1.24% | 534,658 | - |
| 309 | TARA | Protara Therapeutics, Inc. | 223.97M | -1.04% | 354,422 | - |
| 310 | ADAG | Adagene Inc. | 221.91M | 1.07% | 184,797 | 9.29M |
| 311 | GLSI | Greenwich LifeSciences, Inc. | 221.35M | 0.33% | 44,695 | - |
| 312 | KROS | Keros Therapeutics, Inc. | 221.27M | -1.33% | 93,125 | 15.01M |
| 313 | PLX | Protalix BioTherapeutics, Inc. | 219.15M | 1.87% | 591,093 | 80.62M |
| 314 | ANTX | AN2 Therapeutics, Inc. | 218.87M | 1.22% | 162,921 | - |
| 315 | SLGL | Sol-Gel Technologies Ltd. | 218.60M | -3.48% | 79,529 | 1.80M |
| 316 | NMRA | Neumora Therapeutics, Inc. | 213.26M | -5.42% | 390,920 | - |
| 317 | MSLE | Satellos Bioscience Inc. | 212.73M | -0.50% | 39,625 | - |
| 318 | TNXP | Tonix Pharmaceuticals Holding Corp. | 211.13M | -4.05% | 216,654 | 29.10M |
| 319 | PEPG | PepGen Inc. | 210.55M | -3.49% | 679,597 | - |
| 320 | CHRS | Coherus Oncology, Inc. | 207.80M | 1.89% | 784,331 | 50.94M |
| 321 | CUE | Cue Biopharma, Inc. | 205.66M | -7.18% | 127,570 | 37.66M |
| 322 | ABOS | Acumen Pharmaceuticals, Inc. | 205.38M | -0.35% | 282,175 | - |
| 323 | NKTX | Nkarta, Inc. | 201.27M | -3.44% | 340,449 | - |
| 324 | DTIL | Precision BioSciences, Inc. | 199.84M | -0.14% | 106,252 | 45.06M |
| 325 | ORMP | Oramed Pharmaceuticals Inc. | 198.00M | -0.42% | 95,881 | 2.00M |
| 326 | NERV | Minerva Neurosciences, Inc. | 197.67M | 0.49% | 40,797 | - |
| 327 | VYGR | Voyager Therapeutics, Inc. | 196.56M | -1.85% | 228,207 | 34.46M |
| 328 | NBP | NovaBridge Biosciences | 196.04M | -0.59% | 102,642 | - |
| 329 | ACOG | Alpha Cognition Inc. | 194.97M | -1.94% | 63,928 | 15.26M |
| 330 | ARMP | Armata Pharmaceuticals, Inc. | 191.49M | -4.81% | 92,128 | 5.54M |
| 331 | KRRO | Korro Bio, Inc. | 190.18M | -0.12% | 110,376 | 2.38M |
| 332 | IPHA | Innate Pharma S.A. | 180.97M | -2.05% | 7,494 | 10.57M |
| 333 | RNA | Atrium Therapeutics, Inc. | 177.73M | -1.14% | 310,187 | 35.84M |
| 334 | MDWD | MediWound Ltd. | 177.00M | -0.94% | 79,481 | 11.86M |
| 335 | CNTN | Canton Strategic Holdings, Inc. | 171.71M | -2.49% | 370,235 | 1.50M |
| 336 | MOLN | Molecular Partners AG | 163.58M | -2.07% | 1,055 | 856.30K |
| 337 | IMUX | Immunic, Inc. | 161.69M | -2.79% | 234,034 | - |
| 338 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 161.31M | -5.87% | 470,974 | - |
| 339 | OTLK | Outlook Therapeutics, Inc. | 158.92M | 1.38% | 2,629,864 | -1.16M |
| 340 | HUMA | Humacyte, Inc. | 157.93M | -1.81% | 2,298,173 | 2.12M |
| 341 | SPRB | Spruce Biosciences, Inc. | 157.64M | -1.60% | 102,019 | 697.00K |
| 342 | CDXS | Codexis, Inc. | 155.56M | -0.66% | 337,267 | 77.68M |
| 343 | EQ | Equillium, Inc. | 154.08M | -5.08% | 342,068 | 4.39M |
| 344 | KZIA | Kazia Therapeutics Limited | 152.11M | -6.57% | 328,892 | 1.27M |
| 345 | MIST | Milestone Pharmaceuticals Inc. | 149.37M | -0.93% | 923,595 | 2.34M |
| 346 | MENS | Jyong Biotech Ltd. | 149.21M | -6.94% | 52,072 | - |
| 347 | LENZ | LENZ Therapeutics, Inc. | 147.68M | -4.28% | 351,187 | 21.48M |
| 348 | CRBU | Caribou Biosciences, Inc. | 147.41M | -4.51% | 988,699 | 10.04M |
| 349 | UNCY | Unicycive Therapeutics, Inc. | 147.08M | 3.13% | 1,061,191 | - |
| 350 | NRXP | NRx Pharmaceuticals, Inc. | 146.66M | 0.59% | 392,145 | 3.39M |
| 351 | TNYA | Tenaya Therapeutics, Inc. | 144.22M | -2.69% | 2,118,573 | 1.34M |
| 352 | INO | Inovio Pharmaceuticals, Inc. | 133.90M | -1.89% | 1,675,907 | 65.34K |
| 353 | OKUR | OnKure Therapeutics, Inc. | 131.61M | -3.85% | 127,821 | - |
| 354 | HURA | TuHURA Biosciences, Inc. | 129.37M | 1.00% | 270,193 | - |
| 355 | CNTB | Connect Biopharma Holdings Limited | 128.47M | 1.49% | 553,883 | 2.95M |
| 356 | TLSA | Tiziana Life Sciences Ltd | 125.70M | -0.47% | 178,017 | - |
| 357 | BMEA | Biomea Fusion, Inc. | 124.31M | -7.05% | 2,249,389 | - |
| 358 | NAUT | Nautilus Biotechnology, Inc. | 124.09M | -12.94% | 1,789,114 | 190.00K |
| 359 | CBUS | Cibus, Inc. | 120.38M | -0.94% | 50,847 | 4.35M |
| 360 | PMN | ProMIS Neurosciences, Inc. | 119.36M | -7.34% | 48,686 | - |
| 361 | ENGN | enGene Therapeutics Inc. | 118.57M | -4.32% | 462,196 | - |
| 362 | CNXU | Conexeu Sciences Inc. | 115.46M | -3.25% | 148,209 | - |
| 363 | RANI | Rani Therapeutics Holdings, Inc. | 115.19M | -1.62% | 167,117 | 4.88M |
| 364 | VANI | Vivani Medical, Inc. | 113.21M | -4.56% | 236,547 | - |
| 365 | TENX | Tenax Therapeutics, Inc. | 112.85M | -7.51% | 3,303,590 | - |
| 366 | BDTX | Black Diamond Therapeutics, Inc. | 111.46M | -7.62% | 527,053 | 70.00M |
| 367 | GNLX | Genelux Corporation | 110.46M | -2.18% | 496,766 | 8.00K |
| 368 | PMVP | PMV Pharmaceuticals, Inc. | 109.12M | 5.09% | 531,292 | - |
| 369 | SEER | Seer, Inc. | 107.98M | 0.52% | 67,887 | 14.22M |
| 370 | COYA | Coya Therapeutics, Inc. | 105.67M | -2.28% | 73,351 | 8.02M |
| 371 | PYPD | PolyPid Ltd. | 104.81M | -0.77% | 56,173 | - |
| 372 | AARD | Aardvark Therapeutics, Inc. | 104.17M | -3.25% | 125,280 | - |
| 373 | ACET | Adicet Bio, Inc. | 103.55M | 0.84% | 99,425 | - |
| 374 | GUTS | Fractyl Health, Inc. | 103.47M | 1.56% | 575,239 | 3.00K |
| 375 | PLYX | Polaryx Therapeutics, Inc. | 100.69M | -2.88% | 14,934 | - |
| 376 | ONCY | Oncolytics Biotech Inc. | 97.24M | -4.08% | 3,591,599 | - |
| 377 | ATRA | Atara Biotherapeutics, Inc. | 97.06M | -2.42% | 17,046 | 6.19M |
| 378 | ANIX | Anixa Biosciences, Inc. | 93.07M | -3.34% | 337,446 | - |
| 379 | CGTX | Cognition Therapeutics, Inc. | 92.95M | -1.26% | 257,752 | - |
| 380 | NTHI | NeOnc Technologies Holdings, Inc. | 90.98M | 1.10% | 112,627 | 39.99K |
| 381 | RLYB | Rallybio Corporation | 89.85M | -0.29% | 2,342 | 646.00K |
| 382 | ICCC | ImmuCell Corporation | 89.55M | -0.50% | 10,871 | 30.68M |
| 383 | ALDX | Aldeyra Therapeutics, Inc. | 88.68M | -2.00% | 359,865 | - |
| 384 | CRDF | Cardiff Oncology, Inc. | 88.30M | 8.10% | 407,935 | 508.00K |
| 385 | PTHS | Pelthos Therapeutics Inc. | 87.83M | -2.05% | 50,906 | 43.30M |
| 386 | ACRV | Acrivon Therapeutics, Inc. | 86.56M | 1.51% | 251,250 | - |
| 387 | FBIO | Fortress Biotech, Inc. | 86.55M | -1.33% | 253,435 | 68.47M |
| 388 | MNOV | MediciNova, Inc. | 85.89M | -2.51% | 51,497 | 920.48K |
| 389 | VRCA | Verrica Pharmaceuticals Inc. | 85.03M | -2.17% | 51,958 | 30.32M |
| 390 | OSTX | OS Therapies Incorporated | 83.72M | -2.42% | 453,402 | - |
| 391 | TELO | Telomir Pharmaceuticals, Inc. | 81.50M | -2.87% | 25,245 | - |
| 392 | KLRS | Kalaris Therapeutics, Inc. | 80.22M | -2.88% | 55,639 | - |
| 393 | MAIA | MAIA Biotechnology, Inc. | 79.68M | -1.50% | 281,088 | - |
| 394 | YARW | Yarrow Bioscience, Inc. | 78.99M | -3.09% | 34,348 | - |
| 395 | RNXT | RenovoRx, Inc. | 78.53M | -12.78% | 1,457,745 | 1.98M |
| 396 | IBIO | iBio, Inc. | 78.45M | -3.17% | 261,203 | 100.00K |
| 397 | NTRB | Nutriband Inc. | 77.67M | 10.17% | 105,928 | 1.62M |
| 398 | BSEM | BioStem Technologies, Inc. | 76.75M | 2.14% | 82,135 | 34.59M |
| 399 | OKYO | OKYO Pharma Limited | 75.77M | -0.43% | 135,353 | - |
| 400 | ATHE | Alterity Therapeutics Limited | 75.22M | -6.89% | 40,406 | 2.50M |
| 401 | CING | Cingulate Inc. | 75.11M | -0.86% | 101,261 | - |
| 402 | GANX | Gain Therapeutics, Inc. | 74.41M | -0.87% | 432,531 | - |
| 403 | PLRX | Pliant Therapeutics, Inc. | 71.21M | - | 193,604 | - |
| 404 | NRXS | NeurAxis, Inc. | 70.89M | -1.48% | 43,493 | 5.32M |
| 405 | CSBR | Champions Oncology, Inc. | 70.86M | 1.80% | 10,944 | 59.43M |
| 406 | GOSS | Gossamer Bio, Inc. | 69.07M | -11.52% | 11,873,453 | 53.29M |
| 407 | RNTX | Rein Therapeutics Inc. | 67.08M | -6.04% | 234,754 | - |
| 408 | LONA | LeonaBio, Inc. | 65.86M | -0.71% | 40,090 | - |
| 409 | XBIT | XBiotech Inc. | 65.85M | -0.92% | 18,524 | - |
| 410 | SPRO | Spero Therapeutics, Inc. | 65.81M | -3.42% | 512,317 | 47.00M |
| 411 | ELOX | Eloxx Pharmaceuticals, Inc. | 65.59M | -1.93% | 20,189 | - |
| 412 | DWTX | Dogwood Therapeutics, Inc. | 65.27M | -1.03% | 35,918 | - |
| 413 | INMB | INmune Bio Inc. | 64.53M | -5.49% | 336,562 | 50.00K |
| 414 | BOLD | Boundless Bio, Inc. | 64.15M | -1.05% | 21,004 | - |
| 415 | EDSA | Edesa Biotech, Inc. | 63.91M | 0.21% | 34,217 | - |
| 416 | ALPS | Alps Group Inc | 63.66M | -0.64% | 1,681 | 3.74M |
| 417 | SER | Serina Therapeutics, Inc. | 61.99M | -5.03% | 53,752 | 130.00K |
| 418 | HRTX | Heron Therapeutics, Inc. | 61.70M | -2.40% | 776,703 | 151.18M |
| 419 | INKT | MiNK Therapeutics, Inc. | 61.59M | 1.43% | 21,523 | - |
| 420 | HYFT | MindWalk Holdings Corp. | 60.85M | 0.39% | 58,746 | 11.43M |
| 421 | XLO | Xilio Therapeutics, Inc. | 59.42M | 0.67% | 10,884 | 64.09M |
| 422 | IMA | ImageneBio, Inc. | 57.21M | 0.60% | 17,075 | 800.00K |
| 423 | EXOZ | eXoZymes, Inc. | 57.17M | -0.16% | 7,935 | -700.00 |
| 424 | ELTX | Elicio Therapeutics, Inc. | 55.59M | -2.98% | 268,972 | - |
| 425 | HYPD | Hyperion DeFi, Inc. | 55.16M | -3.27% | 396,431 | 1.40M |
| 426 | APLM | Apollomics, Inc. | 53.52M | -2.05% | 3,760 | 8.84M |
| 427 | ANVS | Annovis Bio, Inc. | 50.91M | -2.05% | 1,267,710 | - |
| 428 | IBO | Impact BioMedical Inc. | 50.90M | -4.38% | 59,008 | 35.00K |
| 429 | MCRB | Seres Therapeutics, Inc. | 50.60M | -3.60% | 23,260 | 1.88M |
| 430 | TIL | Instil Bio, Inc. | 50.19M | -2.37% | 9,484 | - |
| 431 | HOWL | Werewolf Therapeutics, Inc. | 47.42M | 1.12% | 691,556 | 21.00M |
| 432 | GRCE | Grace Therapeutics, Inc. | 46.91M | 4.21% | 326,971 | - |
| 433 | IMMP | Immutep Limited | 46.76M | -7.01% | 121,971 | 13.79M |
| 434 | TVGN | Tevogen Inc. | 45.83M | -4.12% | 1,654 | - |
| 435 | MGX | Metagenomi Therapeutics, Inc. | 44.20M | 1.74% | 432,190 | 13.56M |
| 436 | VERU | Veru Inc. | 42.37M | 0.20% | 158,876 | 16.89M |
| 437 | ATYR | aTyr Pharma, Inc. | 42.31M | -5.29% | 731,603 | 190.00K |
| 438 | CELU | Celularity Inc. | 41.45M | -0.56% | 125,973 | 26.55M |
| 439 | ATNM | Actinium Pharmaceuticals, Inc. | 39.93M | 3.25% | 209,998 | 35.09M |
| 440 | MREO | Mereo BioPharma Group plc | 39.38M | 1.69% | 488,215 | 500.00K |
| 441 | FLNA | Filana Therapeutics, Inc. | 38.15M | -2.37% | 263,411 | - |
| 442 | CRVO | CervoMed Inc. | 37.65M | -0.80% | 80,101 | 331.30K |
| 443 | NXTC | NextCure, Inc. | 36.55M | -1.05% | 17,637 | - |
| 444 | KPTI | Karyopharm Therapeutics Inc. | 36.52M | -4.73% | 620,417 | 146.62M |
| 445 | LITS | Lite Strategy, Inc. | 36.41M | 0.94% | 212,211 | - |
| 446 | CNTX | Context Therapeutics Inc. | 33.46M | -1.57% | 555,681 | - |
| 447 | ALGS | Aligos Therapeutics, Inc. | 33.12M | -3.56% | 38,505 | 31.52M |
| 448 | KYNB | Kyntra Bio, Inc. | 32.51M | -0.12% | 81,810 | 4.62M |
| 449 | BYSI | BeyondSpring Inc. | 31.88M | 23.32% | 783,761 | 1.88M |
| 450 | BCTX | BriaCell Therapeutics Corp. | 31.81M | - | 32,551 | - |
| 451 | RNAZ | TransCode Therapeutics, Inc. | 29.63M | -1.69% | 22,096 | - |
| 452 | IGC | IGC Pharma, Inc. | 29.44M | 1.17% | 538,352 | 1.11M |
| 453 | QNCX | Quince Therapeutics, Inc. | 29.17M | -5.39% | 2,989 | - |
| 454 | ESLA | Estrella Immunopharma, Inc. | 29.09M | 4.82% | 80,433 | - |
| 455 | RADX | Radiopharm Theranostics Limited | 28.15M | -0.04% | 17,071 | 9.34M |
| 456 | ACTU | Actuate Therapeutics, Inc. | 27.14M | -10.32% | 156,828 | - |
| 457 | CVM | CEL-SCI Corporation | 26.74M | -1.30% | 64,421 | - |
| 458 | QNTM | Quantum BioPharma Ltd. | 26.61M | -8.10% | 216,541 | - |
| 459 | EVAX | Evaxion A/S | 26.02M | -5.17% | 79,318 | 7.49M |
| 460 | ABVC | ABVC BioPharma, Inc. | 25.15M | - | 41,804 | 797.92K |
| 461 | TVRD | Tvardi Therapeutics, Inc. | 24.54M | -0.54% | 63,711 | - |
| 462 | ATOS | Atossa Therapeutics, Inc. | 23.95M | - | 41,225 | - |
| 463 | JSPR | Jasper Therapeutics, Inc. | 23.73M | 1.75% | 183,135 | - |
| 464 | COCP | Cocrystal Pharma, Inc. | 23.70M | -0.80% | 49,840 | 330.00K |
| 465 | PLRZ | Polyrizon Ltd. | 23.62M | 4.42% | 42,353 | - |
| 466 | NNVC | NanoViricides, Inc. | 23.01M | -2.88% | 533,974 | - |
| 467 | LTRN | Lantern Pharma Inc. | 22.50M | -0.56% | 111,863 | - |
| 468 | CLRB | Cellectar Biosciences, Inc. | 22.50M | 0.63% | 14,511 | - |
| 469 | TCRX | TScan Therapeutics, Inc. | 21.65M | -3.24% | 780,719 | 7.11M |
| 470 | LGVN | Longeveron Inc. | 21.06M | 0.38% | 34,537 | 1.19M |
| 471 | AKTX | Akari Therapeutics, Plc | 20.99M | 1.99% | 156,811 | - |
| 472 | PTN | Palatin Technologies, Inc. | 20.94M | -3.24% | 19,013 | 12.88M |
| 473 | GRDX | GridAI Technologies Corp. | 20.89M | -2.32% | 51,087 | - |
| 474 | GNTA | Genenta Science S.p.A. | 20.85M | 1.27% | 26,762 | - |
| 475 | MRKR | Marker Therapeutics, Inc. | 20.34M | 0.83% | 52,039 | 3.55M |
| 476 | NEUP | Neuphoria Therapeutics Inc. | 20.16M | -0.53% | 32,098 | -13.27K |
| 477 | ALLR | Allarity Therapeutics, Inc. | 20.05M | -0.16% | 74,716 | 345.00K |
| 478 | NCEL | NewcelX Ltd. | 19.26M | 2.62% | 5,261 | - |
| 479 | CMMB | Chemomab Therapeutics Ltd. | 18.84M | -3.35% | 21,486 | - |
| 480 | PBM | Psyence Biomedical Ltd. | 18.77M | 1.65% | 52,118 | - |
| 481 | LPCN | Lipocine Inc. | 18.63M | 0.44% | 6,569 | 1.57M |
| 482 | NIKI | Niki BioSolutions, Inc. | 18.57M | 5.16% | 40,625 | - |
| 483 | KTTA | Pasithea Therapeutics Corp. | 18.38M | -3.46% | 142,911 | - |
| 484 | CNSY | Cerenome, Inc. | 18.29M | -3.21% | 86,139 | 4.20M |
| 485 | ENLV | Enlivex Ltd. | 18.18M | - | 229,259 | - |
| 486 | DYAI | Dyadic International, Inc. | 17.61M | -5.94% | 79,973 | 3.80M |
| 487 | PDSB | PDS Biotechnology Corporation | 17.30M | 5.46% | 12,074,307 | - |
| 488 | BCDA | BioCardia, Inc. | 16.58M | -0.45% | 48,947 | 3.00K |
| 489 | PASG | Passage Bio, Inc. | 16.43M | 3.34% | 24,705 | - |
| 490 | MBRX | Moleculin Biotech, Inc. | 16.11M | 8.10% | 477,832 | - |
| 491 | CTXR | Citius Pharmaceuticals, Inc. | 16.08M | 0.67% | 81,883 | 7.11M |
| 492 | ADIL | Adial Pharmaceuticals, Inc. | 15.76M | 1.18% | 15,248 | - |
| 493 | AEON | AEON Biopharma, Inc. | 15.59M | 35.32% | 194,943,619 | - |
| 494 | MLEC | Moolec Science SA | 15.56M | 12.35% | 10,102 | 7.83M |
| 495 | LSTA | Lisata Therapeutics, Inc. | 15.00M | -12.37% | 232,370 | 100.00K |
| 496 | CALC | CalciMedica, Inc. | 14.71M | -6.10% | 74,999 | - |
| 497 | BIVI | BioVie Inc. | 14.71M | -1.02% | 228,692 | - |
| 498 | HIND | Vyome Holdings, Inc. | 14.39M | -0.49% | 2,779 | 129.73K |
| 499 | ICU | SeaStar Medical Holding Corporation | 13.93M | 1.99% | 59,027 | 1.71M |
| 500 | QNRX | Quoin Pharmaceuticals, Ltd. | 13.92M | -0.57% | 27,177 | - |